annual ROE:
-32.04%+10.57%(+24.81%)Summary
- As of today (August 19, 2025), ELVN annual return on equity is -32.04%, with the most recent change of +10.57% (+24.81%) on December 31, 2024.
- During the last 3 years, ELVN annual ROE has fallen by -6.17% (-23.85%).
- ELVN annual ROE is now -166.71% below its all-time high of 48.03%, reached on December 1, 2019.
Performance
ELVN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-29.83%+1.59%(+5.06%)Summary
- As of today (August 19, 2025), ELVN quarterly return on equity is -29.83%, with the most recent change of +1.59% (+5.06%) on June 30, 2025.
- Over the past year, ELVN quarterly ROE has dropped by -0.44% (-1.50%).
- ELVN quarterly ROE is now -637.48% below its all-time high of 5.55%, reached on December 31, 2022.
Performance
ELVN quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ELVN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.8% | -1.5% |
| 3 y3 years | -23.9% | +49.6% |
| 5 y5 years | -166.7% | -31.2% |
ELVN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2221.8% | +24.8% | -637.5% | +49.6% |
| 5 y | 5-year | -166.7% | +86.2% | -637.5% | +52.4% |
| alltime | all time | -166.7% | +86.2% | -637.5% | +52.4% |
ELVN ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -29.83%(-5.1%) |
| Mar 2025 | - | -31.42%(+3.5%) |
| Dec 2024 | -32.04%(-24.8%) | -30.35%(+1.1%) |
| Sep 2024 | - | -30.03%(+2.2%) |
| Jun 2024 | - | -29.39%(+3.1%) |
| Mar 2024 | - | -28.51%(-7.0%) |
| Dec 2023 | -42.61%(-2921.9%) | -30.64%(+199.8%) |
| Sep 2023 | - | -10.22%(+62.2%) |
| Jun 2023 | - | -6.30%(+264.2%) |
| Mar 2023 | - | -1.73%(-131.2%) |
| Dec 2022 | 1.51% | 5.55%(-109.8%) |
| Sep 2022 | - | -56.35%(-4.9%) |
| Jun 2022 | - | -59.25%(-5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -62.50%(-0.2%) |
| Dec 2021 | -25.87%(-88.9%) | - |
| Dec 2021 | - | -62.60%(+8.0%) |
| Sep 2021 | - | -57.97%(+4.3%) |
| Jun 2021 | - | -55.59%(+16.7%) |
| Mar 2021 | - | -47.62%(+12.4%) |
| Dec 2020 | -232.44%(-583.9%) | -42.35%(+18.5%) |
| Sep 2020 | - | -35.73%(+57.2%) |
| Jun 2020 | - | -22.73%(+72.9%) |
| Mar 2020 | - | -13.15% |
| Dec 2019 | 48.03%(+11.5%) | - |
| Dec 2018 | 43.08%(-3133.8%) | - |
| Dec 2017 | -1.42% | - |
FAQ
- What is Enliven Therapeutics, Inc. annual return on equity?
- What is the all time high annual ROE for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual ROE year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly ROE year-on-year change?
What is Enliven Therapeutics, Inc. annual return on equity?
The current annual ROE of ELVN is -32.04%
What is the all time high annual ROE for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual return on equity is 48.03%
What is Enliven Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, ELVN annual return on equity has changed by +10.57% (+24.81%)
What is Enliven Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of ELVN is -29.83%
What is the all time high quarterly ROE for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly return on equity is 5.55%
What is Enliven Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, ELVN quarterly return on equity has changed by -0.44% (-1.50%)